Chinese Journal of Blood Purification ›› 2023, Vol. 22 ›› Issue (06): 442-445.doi: 10.3969/j.issn.1671-4091.2023.06.009

Previous Articles     Next Articles

The role of sympathetic nerve activation in neointimal hyperplasia of autogenous arteriovenous fistula  

WANG Qun, LIANG Li-ming, KONG Xiang-lei   

  1. Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China; 2Department of Nephrology, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China; 3Nephrology Research Institute of Shandong Province, Jinan 250014, China
  • Received:2022-12-06 Revised:2023-01-14 Online:2023-06-12 Published:2023-06-12
  • Contact: 250014 济南,2山东第一医科大学第一附属医院(山东省千佛山医院)肾病学科; 250014 济南,3山东省肾病研究所 E-mail:kxl1985@163.com
  • Supported by:
    国家自然科学基金青年基金(82000728);中国初级卫生保健基金会面上项目(HT202112220001);齐鲁卫生与健康杰出青年人才项目(A001358)

Abstract: Autologous arteriovenous fistula (AVF) is the most important route of blood access for hemodialysis, and failure of AVF may seriously limit its clinical application. Stenosis in venous outflow tract is a common cause of AVF failure, pathologically due to the neointimal hyperplasia (NIH). The mechanisms underlying NIH include a series of cascade reactions in local vessels, such as inflammation, oxidative stress and vascular remodeling, leading to vascular stenosis and AVF failure. On the other hand, hyperactive sympathetic nerve function is frequently present in end stage renal disease patients, which may also take part in the occurrence of NIH and AVF dysfunction through several pathways. This review focuses on the possible mechanisms of sympathetic activation to the development of NIH, aiming to provide a new theoretical explanation and a new intervention target for the prevention and treatment of AVF failure.

Key words: Sympathetic nerve, End stage renal disease, Arteriovenous fistula, Neointimal hyperplasia, Renal denervation

CLC Number: